Therapeutic effect of tricl... [Trans R Soc Trop Med Hyg. 1992 Jul-Aug] - PubMed

loading

[A clinical trial of triclabendazole in the treatment of human paragonimiasis skrjabini]. [Zhongguo Ji Sheng Chong Xue Yu...]
[A clinical trial of triclabendazole in the treatment of human paragonimiasis skrjabini].
Hu P, Liu YH. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2001; 19(5):305-7.
Treatment of human pulmonary paragonimiasis with triclabendazole: clinical tolerance and drug efficacy. [Trans R Soc Trop Med Hyg. 1998]
Treatment of human pulmonary paragonimiasis with triclabendazole: clinical tolerance and drug efficacy.
Calvopiña M, Guderian RH, Paredes W, Chico M, Cooper PJ. Trans R Soc Trop Med Hyg. 1998 Sep-Oct; 92(5):566-9.
Triclabendazole in the treatment of Paragonimiasis skrjabini. [Chin Med J (Engl). 2003]
Triclabendazole in the treatment of Paragonimiasis skrjabini.
Gao J, Liu Y, Wang X, Hu P. Chin Med J (Engl). 2003 Nov; 116(11):1683-6.
Review Triclabendazole for the treatment of fascioliasis and paragonimiasis. [Expert Opin Investig Drugs. 2005]
Review Triclabendazole for the treatment of fascioliasis and paragonimiasis.
Keiser J, Engels D, Büscher G, Utzinger J. Expert Opin Investig Drugs. 2005 Dec; 14(12):1513-26.
Review Trematode infections. Opisthorchiasis, clonorchiasis, fascioliasis, and paragonimiasis. [Infect Dis Clin North Am. 1993]
Review Trematode infections. Opisthorchiasis, clonorchiasis, fascioliasis, and paragonimiasis.
Harinasuta T, Pungpak S, Keystone JS. Infect Dis Clin North Am. 1993 Sep; 7(3):699-716.

Review Neglected tropical diseases: survey and geometry of randomised evidence. [BMJ. 2012]
Review Neglected tropical diseases: survey and geometry of randomised evidence.
Kappagoda S, Ioannidis JP. BMJ. 2012 Oct 22; 345:e6512. Epub 2012 Oct 22.
Review North American paragonimiasis (Caused by Paragonimus kellicotti) in the context of global paragonimiasis. [Clin Microbiol Rev. 2009]
Review North American paragonimiasis (Caused by Paragonimus kellicotti) in the context of global paragonimiasis.
Procop GW. Clin Microbiol Rev. 2009 Jul; 22(3):415-46.
Effect of food on the bioavailability of triclabendazole in patients with fascioliasis. [Br J Clin Pharmacol. 1998]
Effect of food on the bioavailability of triclabendazole in patients with fascioliasis.
Lecaillon JB, Godbillon J, Campestrini J, Naquira C, Miranda L, Pacheco R, Mull R, Poltera AA. Br J Clin Pharmacol. 1998 Jun; 45(6):601-4.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Therapeutic effect of triclabendazole in patients with paragonimiasis in Cameroo...
Therapeutic effect of triclabendazole in patients with paragonimiasis in Cameroon: a pilot study.
Trans R Soc Trop Med Hyg. 1992 Jul-Aug ;86(4):417.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed